Evaluaciones económicas

Cost-effectiveness study of prophylaxis with emicizumab versus bypassing agents in patients with severe hemophilia A in Peru

Back to article
Type of prophylaxis and pharmacological treatment in base and project scenarios for children and adults from Ministry of Health and Social Security Health Insurance.